Ian Taylor Selected Research

Ian Taylor Research Topics

Disease

7	Neoplasms (Cancer) 04/2014 - 10/2004
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2014 - 10/2004
2	Inflammation (Inflammations) 01/2016 - 01/2015
2	Breast Neoplasms (Breast Cancer) 09/2012 - 10/2004
1	Wounds and Injuries (Trauma) 10/2021
1	Hypesthesia (Numbness) 10/2021
1	Retinal Degeneration 01/2021
1	Metaplasia 01/2016
1	Hyperplasia 01/2016
1	Epilepsy (Aura) 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Migraine Disorders (Migraine) 01/2015
1	Multiple Sclerosis 01/2015
1	Exanthema (Rash) 11/2014
1	Stomatitis 11/2014
1	Adenocarcinoma 10/2014
1	Disease Progression 10/2014
1	Dyspnea (Shortness of Breath) 04/2014
1	Chest Pain (Chest Pains) 04/2014
1	Cough 04/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2012
1	Hypersensitivity (Allergy) 09/2010
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2007
1	Retinal Diseases 01/2007
1	Hepatocellular Carcinoma (Hepatoma) 09/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2006

Drug/Important Bio-Agent (IBA)

6	dacomitinibIBA 12/2014 - 09/2012
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 09/2012
4	ErbB Receptors (EGF Receptor)IBA 10/2014 - 09/2012
3	Tyrosine Kinase InhibitorsIBA 12/2014 - 04/2014
3	Epidermal Growth Factor (EGF)IBA 04/2014 - 09/2012
3	tyrosine receptor (receptor, tyrosine)IBA 09/2006 - 10/2004
3	Sorafenib (BAY 43-9006)FDA Link 09/2006 - 10/2004
3	Phosphotransferases (Kinase)IBA 09/2006 - 10/2004
2	Gefitinib (Iressa)FDA Link 12/2014 - 10/2014
2	raf KinasesIBA 09/2006 - 10/2004
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2006 - 10/2004
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2006 - 10/2004
1	Retinaldehyde (Retinal)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2016
1	LigandsIBA 09/2012
1	Lapatinib (GW572016)FDA Link 09/2012
1	Trastuzumab (Herceptin)FDA Link 09/2012
1	A 7 (A-7)IBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2010
1	anthranilamideIBA 08/2007
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2007
1	Protein Kinase InhibitorsIBA 08/2007
1	Investigational DrugsIBA 01/2007
1	thiamine triphosphorate (TTP)IBA 09/2006
1	Biomarkers (Surrogate Marker)IBA 09/2006
1	Tyrosine (L-Tyrosine)FDA Link 01/2006
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2004
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 10/2004
1	Mitogen-Activated Protein KinasesIBA 10/2004
1	AntibodiesIBA 10/2004

Therapy/Procedure

3	Therapeutics 01/2015 - 04/2014
3	Drug Therapy (Chemotherapy) 11/2014 - 04/2014
1	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2021
1	Vagus Nerve Stimulation 01/2015